A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

NCT05429398 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Linperlisib Tablet

Sponsor

Shanghai YingLi Pharmaceutical Co. Ltd.